Financhill
Back

Novo Nordisk A/S 10K Form

Buy
76

NONOF
Novo Nordisk A/S

Last Price:
186.17
Seasonality Move:
-0.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NONOF News And Ratings

See the #1 stock for the next 7 days that we like better than NONOF

NONOF Financial Statistics

Sales & Book Value

Annual Sales: $25.09B
Cash Flow: $3.2B
Price / Cash Flow: 43.3
Annual Sales: $5.89
Price / Book: 31.56

Profitability

EPS (TTM): 4.21340
Net Income (TTM): $9.52B
Gross Margin: $21.05B
Return on Equity: 82.75%
Return on Assets: 27.17%

Novo Nordisk A/S Earnings Forecast

Key Novo Nordisk A/S Financial Ratios

  • The Gross Profit Margin over the past 39 years for NONOF is 83.92%.
  • The Selling, General & Administrative Expenses for NONOF have been equal to 28.64% of Gross Profit Margin.
  • The Research & Development expenses have been 13.59% of Revenue.
  • The Interest Expense is 0.68% of Operating Income.
  • The Net Earning history of NONOF is 31.38% of Total Revenues.
  • Per Share Earnings over the last 39 years have been positive in 31 years.

Novo Nordisk A/S Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Healthcare
Current Symbol: NONOF
Website: novonordisk.com

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 0.88
Quick Ratio: 0.68

Price-to-Earnings

Trailing P/E Ratio: 53.73
Forward P/E Ratio: 0

NONOF Technical Analysis vs Fundamental Analysis

Buy
76
Novo Nordisk A/S (NONOF) is a Buy

Is Novo Nordisk A/S a Buy or a Sell?

  • Novo Nordisk A/S stock is rated a Buy
    The current Novo Nordisk A/S [NONOF] share price is $186.17. The Score for NONOF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.